Sign up
Log in
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Share
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Canaccord Genuity analyst Richard Close downgraded DocGo Inc. (NASDAQ:DCGO) from Buy to Hold and lowered the price target from $5 to $1.45. DocGo shares closed at $1.40 on Friday. See how other analysts view this stock.
  • Barrington Research analyst Michael Petusky downgraded the rating for ModivCare Inc. (NASDAQ:MODV) from Outperform to Market Perform. ModivCare shares closed at $1.17 on Friday. See how other analysts view this stock.
  • JP Morgan analyst Ekaterina Knyazkova downgraded Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) from Overweight to Neutral and cut the price target from $45 to $30. Amphastar Pharma shares closed at $24.11 on Friday. See how other analysts view this stock.
  • Bernstein analyst Zhihan Ma downgraded the rating for Target Corporation (NYSE:TGT) from Market Perform to Underperform and lowered the price target from $97 to $82. Target shares closed at $96.40 on Friday. See how other analysts view this stock.
  • Goldman Sachs analyst Stephen Laszczyk downgraded Warner Music Group Corp. (NASDAQ:WMG) from Buy to Neutral and slashed the price target from $35 to $28. Warner Music shares closed at $27.36 on Friday. See how other analysts view this stock.

Considering buying TGT stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.